Search

everythinglearnresearchcommunity

for

Search:↓

JAK inhibitors may help treat certain types of hair loss, but more research is needed.

Decreasing MIG6 can increase the movement and invasiveness of MEK-inhibited mutant NRAS melanoma, particularly when stimulated by EGF.

Immunomodulatory therapies are effective for treating cutaneous lymphoma, particularly in early stages.

JAK1 inhibitors can help reduce itchiness in atopic dermatitis.

Specific immune cells cause alopecia areata and blocking certain proteins can prevent it.

Ritlecitinib shows promise for hair regrowth in alopecia areata patients.

The treatment was ineffective in humans.

JAK inhibitors are effective and safe for treating severe alopecia areata.

Some breast cancer treatments cause hair loss similar to male pattern baldness, which can be improved with minoxidil.

ILC1-like cells can independently cause alopecia areata by affecting hair follicles.

New compounds called benzoquinolinones may treat conditions linked to excess DHT.

A protein called IL-36γ causes skin side effects from certain cancer treatments when combined with a common skin bacteria.

A new protein, mK6irs, is found in specific hair layers and may help understand hair growth and diseases.

Ritlecitinib effectively treats alopecia areata in patients 12 and older with fewer side effects.

Two new compounds were found to effectively reduce hair growth in mice.

M50054 may help treat hepatitis and hair loss from chemotherapy.

Blocking JAK-STAT signaling can lead to hair growth.

A new compound may treat benign prostatic hyperplasia better than finasteride.

5αR inhibitors help slow early prostate cancer cell growth, suggesting combined treatments are needed.

Chemotherapy-induced hair loss is partly due to decreased laminin-511 and increased laminin-332.

Two existing drugs may help treat COVID-19 by inhibiting a key viral protein.

ICP5249 helps hair grow by activating a specific cell pathway.

Tofacitinib helped improve symptoms and hair growth in a patient with Aicardi-Goutières syndrome.

A patient with Alopecia Areata had complete hair regrowth after using the drug baricitinib.

Targeted cancer therapies often cause skin problems that need careful management to improve patient quality of life and treatment success.

Hedgehog pathway inhibitors used for skin cancer can cause significant hair loss, which may improve after stopping the medication.

A patient with advanced kidney cancer and no hepatitis C developed skin inflammation due to a drug called interferon alpha-2a.

Ritlecitinib may cause serious side effects like blood clots in alopecia areata patients.

Kv1.3 blockers may help treat alopecia areata and promote hair regrowth.

Baricitinib is effective in promoting hair growth in severe alopecia areata.